Shanghai Henlius Biotech Co., Ltd (HKG: 2696) has announced significant changes in its executive leadership. Zhang Wenjie, who has been instrumental in the company’s growth since joining in March 2019, has resigned from his position as CEO. Despite this change, Zhang will continue to contribute to Henlius Biotech as the chairman and executive director. Under his leadership, the company successfully launched five products domestically and one product internationally.
Zhu Jun Appointed as New CEO
Zhu Jun has been appointed to take over the helm as CEO of Henlius Biotech. In addition to his role as CEO, Zhu will also oversee the daily management of the company as president and will act as the chief financial officer (CFO). This appointment comes at a pivotal time for the company as it continues to expand its operations and product portfolio.-Fineline Info & Tech
